Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment.

MLA

Ando, Hidenori, et al. “Oral Administration of Sodium Bicarbonate Can Enhance the Therapeutic Outcome of Doxil® via Neutralizing the Acidic Tumor Microenvironment.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 350, Oct. 2022, pp. 414–20. EBSCOhost, https://doi.org/10.1016/j.jconrel.2022.08.031.

APA

Ando, H., Ikeda, A., Tagami, M., Matsuo, N. C. A., Shimizu, T., Ishima, Y., Eshima, K., & Ishida, T. (2022). Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment. Journal of Controlled Release : Official Journal of the Controlled Release Society, 350, 414–420. https://doi.org/10.1016/j.jconrel.2022.08.031

Chicago

Ando, Hidenori, Ai Ikeda, Maho Tagami, Nana Cristina Amorim Matsuo, Taro Shimizu, Yu Ishima, Kiyoshi Eshima, and Tatsuhiro Ishida. 2022. “Oral Administration of Sodium Bicarbonate Can Enhance the Therapeutic Outcome of Doxil® via Neutralizing the Acidic Tumor Microenvironment.” Journal of Controlled Release : Official Journal of the Controlled Release Society 350 (October): 414–20. doi:10.1016/j.jconrel.2022.08.031.